Following the post-hoc Dunn’s multiple comparisons tests, it was noted that there was a significant difference in the concentration of TGF-β1 between CKD-P and HP groups (P < 0.05) (Fig. 5B). The gene discussed is TGFB1; the disease is chronic kidney disease.